Perfusate flow rate: an overlooked factor in hyperthermic intraperitoneal chemotherapy (HIPEC)?

Saved in:
Bibliographic Details
Main Authors: Theile, Dirk (Author) , Czock, David (Author)
Format: Article (Journal) Editorial
Language:English
Published: December 2024
In: Annals of surgical oncology
Year: 2024, Volume: 31, Issue: 13, Pages: 8614-8615
ISSN:1534-4681
DOI:10.1245/s10434-024-16060-8
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1245/s10434-024-16060-8
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1245/s10434-024-16060-8#article-info
Get full text
Author Notes:Dirk Theile, PhD, and David Czock, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1920208569
003 DE-627
005 20250717002056.0
007 cr uuu---uuuuu
008 250320s2024 xx |||||o 00| ||eng c
024 7 |a 10.1245/s10434-024-16060-8  |2 doi 
035 |a (DE-627)1920208569 
035 |a (DE-599)KXP1920208569 
035 |a (OCoLC)1528043380 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Theile, Dirk  |e VerfasserIn  |0 (DE-588)1019114428  |0 (DE-627)684195658  |0 (DE-576)356996360  |4 aut 
245 1 0 |a Perfusate flow rate  |b an overlooked factor in hyperthermic intraperitoneal chemotherapy (HIPEC)?  |c Dirk Theile, PhD, and David Czock, MD 
264 1 |c December 2024 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 17. August 2024 
500 |a Gesehen am 20.03.2025f 
700 1 |a Czock, David  |e VerfasserIn  |0 (DE-588)120971011  |0 (DE-627)705128253  |0 (DE-576)180276719  |4 aut 
773 0 8 |i Enthalten in  |t Annals of surgical oncology  |d Berlin [u.a.] : Springer, 1994  |g 31(2024), 13 vom: Dez., Seite 8614-8615  |h Online-Ressource  |w (DE-627)343969947  |w (DE-600)2074021-9  |w (DE-576)099879212  |x 1534-4681  |7 nnas  |a Perfusate flow rate an overlooked factor in hyperthermic intraperitoneal chemotherapy (HIPEC)? 
773 1 8 |g volume:31  |g year:2024  |g number:13  |g month:12  |g pages:8614-8615  |g extent:2  |a Perfusate flow rate an overlooked factor in hyperthermic intraperitoneal chemotherapy (HIPEC)? 
856 4 0 |u https://doi.org/10.1245/s10434-024-16060-8  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1245/s10434-024-16060-8#article-info  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250320 
993 |a Editorial 
994 |a 2024 
998 |g 120971011  |a Czock, David  |m 120971011:Czock, David  |d 910000  |d 910100  |d 50000  |e 910000PC120971011  |e 910100PC120971011  |e 50000PC120971011  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 2  |y j 
998 |g 1019114428  |a Theile, Dirk  |m 1019114428:Theile, Dirk  |d 910000  |d 910100  |d 50000  |e 910000PT1019114428  |e 910100PT1019114428  |e 50000PT1019114428  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1920208569  |e 4689000204 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"December 2024"}],"person":[{"display":"Theile, Dirk","role":"aut","given":"Dirk","family":"Theile","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Czock, David","given":"David","roleDisplay":"VerfasserIn","family":"Czock"}],"name":{"displayForm":["Dirk Theile, PhD, and David Czock, MD"]},"physDesc":[{"extent":"2 S."}],"relHost":[{"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"Society of Surgical Oncology"}],"pubHistory":["1.1994 -"],"recId":"343969947","physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"13","volume":"31","text":"31(2024), 13 vom: Dez., Seite 8614-8615","pages":"8614-8615","year":"2024","extent":"2"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"1994-","dateIssuedKey":"1994","publisherPlace":"Berlin [u.a.] ; Philadelphia, Pa.","publisher":"Springer ; Lippincott Williams & Wilkins"}],"language":["eng"],"note":["Gesehen am 26.09.25"],"disp":"Perfusate flow rate an overlooked factor in hyperthermic intraperitoneal chemotherapy (HIPEC)?Annals of surgical oncology","title":[{"title_sort":"Annals of surgical oncology","title":"Annals of surgical oncology","subtitle":"the official journal of the Society of Surgical Oncology"}],"id":{"issn":["1534-4681"],"zdb":["2074021-9"],"eki":["343969947"]}}],"id":{"eki":["1920208569"],"doi":["10.1245/s10434-024-16060-8"]},"title":[{"subtitle":"an overlooked factor in hyperthermic intraperitoneal chemotherapy (HIPEC)?","title":"Perfusate flow rate","title_sort":"Perfusate flow rate"}],"recId":"1920208569","note":["Veröffentlicht: 17. August 2024","Gesehen am 20.03.2025f"]} 
SRT |a THEILEDIRKPERFUSATEF2024